Evaluation Summary:
Microglia are a key cell type in the brain that clear debris following tissue injury, infections, or in neurodegenerative diseases. This role is influenced strongly by directed migration of microglia towards the regions of brain injury or infection. TREM2 is a myeloid protein expressed in microglia that has been linked to Alzheimer's Disease, but the mechanisms of how TREM2 loss-of-function mutations affect microglial function is unclear. Here, Jairaman and colleagues address this question using CRISPR-based knockout of TREM2 in human iPSC-derived microglia. The study finds that TREM2 KO microglia have greatly exaggerated ADP/ATP evoked Ca signals, which is found to arise from increases in P2Y12 and P2Y13 receptor expression and enhanced receptor-evoked Ca signaling. TREM2 KO microglia show alterations in cell migration, which include, on the one hand, increased cell motility, but also reduced turning, and importantly, markedly reduced directed migration. The experiments and analysis are carefully performed using appropriate controls and the results are novel and add to our understanding of how loss-of-function TREM2 mutations impact microglial migration and the ensuing microglia-mediated clearance of plaques and damage seen in AD. Several weaknesses cloud the interpretation, but if appropriately addressed, this could be an important paper for the field.
(This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #2 agreed to share their name with the authors.)